Wednesday, July 8, 2026

Patent intelligence · US

US 9283256

Antibacterial composition comprising Salvia extracts

granted A61KA61K31/343A61K36/537A61P
Status granted
Linked drugs 1
Pipeline programs 6
Years to expiry 10
Applicant portfolio 39
Patent details — US 9283256
Jurisdiction
US
Status
granted
Grant date
Mar 15, 2016
Expiration
Mar 10, 2036
Claims
20
CPC classes
A61K, A61K31/343, A61K36/537, A61P
View on Google Patents ↗

Quick answer

US 9283256 (Antibacterial composition comprising Salvia extracts) is held by Botanic Century (Beijing) Co. Ltd.. Status: granted. Granted Mar 15, 2016. Expires Mar 10, 2036 (10 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
20
CPC classes
A61K, A61K31/343, A61K36/537, A61P, A61P17/10, A61P31/04

More from Botanic Century (Beijing) Co. Ltd.

Related pharmaceutical patents in our USPTO index.

  1. US 12274710

    Compound for regulating body weight imbalance, composition thereof and application thereof

    GUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD · Expires Apr 10, 2045

    granted
  2. US 12269888

    Artificial cell death polypeptide for chimeric antigen receptor and uses thereof

    Century Therapeutics, Inc. · Expires Apr 3, 2045

    granted
  3. US 12194049

    Composition for treating carbapenem antibiotic-resistant Acinetobacter baumannii infection

    GUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD · Expires Jan 9, 2045

    granted
  4. US 12084670

    Regulating alkaloids

    22ND CENTURY LIMITED, LLC · Expires Sep 5, 2044

    granted
  5. US 11883432

    Chimeric antigen receptor system with adaptable receptor specificity

    Century Therapeutics, Inc. · Expires Jan 25, 2044

    granted
  6. US 11865155

    Plant extract obtained from Morus plant leaves which has an IC50 value to inhibit a-glucosidase I at a concentration of less than 90 uG/ml, compositions containing same, method of extraction and uses thereof

    Botanic Century (Beijing) Co. Ltd. · Expires Jan 4, 2044

    granted
  7. US 11667924

    Increasing levels of nicotinic alkaloids in plants

    22ND CENTURY LIMITED, LLC · Expires Jun 1, 2043

    granted
  8. US 11661459

    Artificial cell death polypeptide for chimeric antigen receptor and uses thereof

    Century Therapeutics, Inc. · Expires May 25, 2043

    granted

Frequently asked questions

What is US patent 9283256?

US 9283256 (Antibacterial composition comprising Salvia extracts) is held by Botanic Century (Beijing) Co. Ltd.. Status: granted. Granted Mar 15, 2016. Expires Mar 10, 2036 (10 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 9283256?

Botanic Century (Beijing) Co. Ltd. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 39 pharmaceutical patents for this assignee.

When does US 9283256 expire?

Our index shows an expiration date of Mar 10, 2036 (10 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.